Screening for bacterial vaginosis in pregnancy

American Journal of Preventive Medicine

Volumn 20, Issue 3 SUPPL., 2001, Pages 62-72

  Guise, Jeanne Marie ^a,b   Mahon, Susan M ^b   Aickin, Mikel ^c   Helfand, Mark ^b,d   Peipert, Jeffrey F ^e   Westhoff, Carolyn ^f  

^a Department of Obstetrics and Gynecology ^*  (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e WOMEN AND INFANTS HOSPITAL   (United States)

^f College of Physicians and Surgeons ^*  (United States)

Author keywords

Bacterial vaginosis; Evidence based medicine; Mass screening; MEDLINE; Methods; Pregnancy; Preventive health services; Vaginitis

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MASS SCREENING; META ANALYSIS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK; VAGINITIS;

FEMALE; HUMANS; INFANT, NEWBORN; MASS SCREENING; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK; VAGINOSIS, BACTERIAL;

EID: 0035318597     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-3797(01)00256-2     Document Type: Article

References (41)

1. Amsel R, Totten PA, Spiegel CA, Chen KG, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
2. Gravett MG, Nelson HP, DeRouen T, Critchlow G, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-903.
3. Gravett MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986;67:229-37.
4. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. New Engl J Med 1988;319:972-8.
5. Goldenberg RL, Iams JD, Mercer BM, et al. The preterm prediction study: the value of new vs. standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Pub Health 1998;88:233-8.
6. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-42.
7. Meis PJ, Goldenberg RL, Mercer B, et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1995;173:1231-5.
8. Carey JC, Yaffe SJ, Catz C. The Vaginal Infections and Prematurity Study: an overview. Clin Obstet Gynecol 1993;36:809-20.
9. Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-7.
10. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-72.
11. Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1992;166:938-44.
12. Pastore LM, Royce RA, Jackson TPJ, Savitz DA, Kreaden US. Association between bacterial vaginosis and fetal fibronectin at 24-29 weeks' gestation. Obstet Gynecol 1999;93:117-23.
13. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1996;174:1618-21.
14. Cristiano L, Rampello S, Noris C, Valota V. Bacterial vaginosis: prevalence in an Italian population of asymptomatic pregnant women and diagnostic aspects. Eur J Epidemiol 1996;12:383-90.
15. Brocklehurst P, Hannah M, McDonald H. The management of bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews. 1998;3.
16. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect (published erratum appears in BMJ 1995 Apr 22;310(6986):1056). BMJ 1995;310:452-4.
17. STATA Corp. STATA, 5th ed. College Station, TX: STATA Corporation, 1997.
18. Edwards AWE. Likelihood. Cambridge, UK: Cambridge University Press; 1972.
19. Clayton D, Hills M. Statistical Methods in Epidemiology. Oxford, UK: Oxford University Press; 1993.
20. Royal R. Statistical Evidence: a Likelihood Paradigm. London, UK: Chapman & Hall; 1997.
21. Berger JO, Lisea B, Wolpert RL. Integrated likelihood methods for eliminating nuisance parameters. Stat Sci 1999;14:1-28.
22. Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ 1998;317:307-12.
23. Thomason JL, Gelbart SM, Anderson RJ, Walt AK, Osypowski PJ, Broekhuizen FF. Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol 1990;162:155-60.
24. Krohn MA, Hillier SL, Eschenbach DA. Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol 1989;27:1266-71.
25. Eschenbach DA. Bacterial vaginosis: emphasis on upper genital tract complications. Obstet Gynecol Clin North Am 1989;16:593-610.
26. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol 1983;18:170-7.
27. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
28. Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. Validity of the vaginal Gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996;88:573-6.
29. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47: 70-4.
30. McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-60.
31. Joesoef MR, Hillier SL, Wiknjosastro G, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-31.
32. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 1992; 268:92-5.
33. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. AmJ Obstet Gynecol 1995; 172:525-9.
34. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997;44:179-82.
35. Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999;106:652-7.
36. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-9.
37. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
38. McDonald HM, O'Loughlin JA, Vigneswaran R, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1391-7.
39. Carey JC, Kiebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-40.
40. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
41. Alvi SA, Lamont RF. Pregnancy outcome following the use of clindamycin intravaginal cream. J Soc Gynecol Investig 1999;6:94A.